NCT Number: NCT02207803
A Culturally Sensitive Intervention for TBI Caregivers in Latin America
Traumatic brain injury (TBI) patients in Latin America experience high levels of disability and extremely poor functional outcomes, and their informal caregivers play a key role in their rehabilitation and care. To improve TBI rehabilitation through stronger informal caregiving, the proposed study will develop and evaluate an evidence--based and culturally sensitive Transition Assistance Program for informal caregivers of patients with TBI in Latin America during the patient's transition from hospital to home. This study will generate findings that can provide empirically supported guidance to clinicians regarding the provision of culturally tailored rehabilitation services for TBI caregivers in Latin America and in the U.S.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–85 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Pontificia Universidad Javeriana Cali, Cali, Colombia
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
TBI Patient Inclusion Criteria:
- Will be discharged home and not to a nursing home
- Give permission for their caregiver to participate
- Sign an informed consent
- Have the ability to communicate over the phone for data collection
- Are between 18-60 years of age
Caregiver Inclusion Criteria
- Have a telephone in the home or cellular phone and are able to talk on the phone
- Sign an informed consent
- Score at least a 13 on a health literacy screening tool
- Are between 18-85 years of age
Treatment and study plan
Primary outcomes
-
Zarit Burden Interview
Time frame: 2 months post-hospital discharge
22-item measure of caregiver self-reported burden. Response options for each item range from 0-4, and total scores range from 0-88, with higher scores indicating greater self-reported burden. Only total scores are reported here.
Secondary outcomes
-
Exemplary Care Scale-Provide Subscale
Time frame: 2 months post-hospital discharge
4-item measure of the patient's report of the quality of care they receive from their caregiver. Response options for each item range from 1-4, and total scores range from 4-16, with higher scores indicating a higher quality of informal care received. Only Provide subscale scores of the Exemplary Care Scale are reported here.
Sponsors and collaborators
Lead sponsor
Virginia Commonwealth University
Other
Collaborators
- Fogarty International Center of the National Institute of Health
Registry information
Important dates
- Study start
- 2015
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- Aug 4, 2014
- Registry last updated
- Oct 18, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Evaluation, Pathogenesis, and Outcome of Subjects With or Suspected Traumatic Brain Injury
NCT01132937
Brain Diseases, Brain Injuries
Bethesda, Maryland, United States
View Trial DetailsA Pilot Study to Identify Biomarkers Associated With Chronic Traumatic Brain Injury
NCT01171131
Brain Diseases, Brain Injuries
Houston, Texas, United States
View Trial DetailsThe Effect of Mannitol Volume With Changes in Osmolarity in Traumatic Brain Injury
NCT06846307
Anesthesia, Brain Diseases
Semarang, Central Java, Indonesia
View Trial DetailsDevelopment and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
NCT06796335
Astrocytoma, Brain Diseases
Copenhagen, Denmark
View Trial Details